Quantcast

Latest Merrimack Pharmaceuticals Inc. Stories

2014-05-01 08:34:14

MM-398 in Combination with 5-FU and Leucovorin Provides New Treatment Option for Patients Previously Treated with Gemcitabine MANHATTAN BEACH, Calif., May 1, 2014 /PRNewswire/ -- The Pancreatic Cancer Action Network is pleased to announce that today Merrimack Pharmaceuticals, Inc., (Merrimack) reported a 1.9 month improvement in survival for patients treated with the combination of its drug, MM-398, with 5-fluorouracil (5-FU) and leucovorin. According to Merrimack, the NAPOLI-1...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.